Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02807844What this trial is testingPhase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced MalignanciesWho this might be right forTriple Negative Breast CancerPancreatic CarcinomaMelanoma+1 more Novartis Pharmaceuticals 141
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599What this trial is testingGEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid TumorsWho this might be right forMalignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more Genmab 350
Not applicableStudy completedNCT02575898What this trial is testingFeasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort StudyWho this might be right forPrimary Malignant Neoplasm of LungPrimary Malignant Neoplasm of Gastrointestinal Tract Dartmouth-Hitchcock Medical Center 23
Early research (Phase 1)Active Not RecruitingNCT04616534What this trial is testingTesting the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid TumorsWho this might be right forAdvanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+19 more National Cancer Institute (NCI) 14
Not applicableStudy completedNCT01970254What this trial is testingWidespread vs. Selective Screening for Hepatitis B Infection Prior to ChemotherapyWho this might be right forCancerHepatitis BHBV+2 more M.D. Anderson Cancer Center 2,206
Testing effectiveness (Phase 2)Ended earlyNCT04424641What this trial is testingA Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more Genmab 48
Testing effectiveness (Phase 2)Study completedNCT01529827What this trial is testingFludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more Roswell Park Cancer Institute 94
Early research (Phase 1)Study completedNCT03508570What this trial is testingNivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisWho this might be right forMalignant Peritoneal NeoplasmMalignant Retroperitoneal NeoplasmMetastatic Cervical Carcinoma+31 more M.D. Anderson Cancer Center 26
Not applicableTemporarily pausedNCT06653192What this trial is testingEUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)Who this might be right forMalignant Biliary ObstructionPancreatic CancerBiliary Tract Neoplasms Hospital Universitari de Bellvitge 120
Early research (Phase 1)Study completedNCT02672865What this trial is testingAdjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric CancerWho this might be right forLocally Advanced Malignant NeoplasmGastric Cancer Loma Linda University 4
Early research (Phase 1)Looking for participantsNCT07658196What this trial is testingTLR9 Immunotherapy for Peritoneal CarcinomatosisWho this might be right forMalignant AscitesColorectal AdenocarcinomaPeritoneal (Metastatic) Cancer+1 more Brown University 24
Testing effectiveness (Phase 2)UnknownNCT03990103What this trial is testingS1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant AscitesWho this might be right forMetastatic Gastric Adenocarcinoma China Medical University, China 66
Testing effectiveness (Phase 2)Looking for participantsNCT07149090What this trial is testingLenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant AscitesWho this might be right forSTOMACH NEOPLASMGastric CancerGastric Cancer Adenocarcinoma Metastatic Asan Medical Center 61
Testing effectiveness (Phase 2)UnknownNCT05587088What this trial is testingEvaluation of the Safety and Efficacy of Esperanza Extract (PA001)Who this might be right forNeoplasm, StomachGastric Neoplasms MalignantPancreatic Neoplasms+6 more Hospital Universitario San Ignacio 82
Not applicableActive Not RecruitingNCT05038254What this trial is testingEnhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsWho this might be right forClinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+42 more M.D. Anderson Cancer Center 750
Testing effectiveness (Phase 2)Active Not RecruitingNCT05669482What this trial is testingStudy of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerWho this might be right forKRAS Activating MutationMetastatic CancerPancreas Cancer+2 more Verastem, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT05795595What this trial is testingA Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsWho this might be right forClear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more CRISPR Therapeutics AG 19
Not applicableUnknownNCT03062072What this trial is testingEmergence of Chemotherapy Related Hyperglycemia in nOn-diabetic PatientsWho this might be right forCancerColon CancerBreast Cancer+1 more National Cancer Center, Korea 300
Early research (Phase 1)Active Not RecruitingNCT03168737What this trial is testing18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in PatientsWho this might be right forMalignant Breast NeoplasmMalignant Colorectal NeoplasmMalignant Pancreatic Neoplasm+1 more M.D. Anderson Cancer Center 25